Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | AOH1160 |
Trade Name | |
Synonyms | |
Drug Descriptions |
AOH1160 is a small molecule inhibitor that specifically targets cancer associated PCNA (caPCNA) and binds to the region between L126 and Y133, thereby interfering with elongation of the replication fork, and subsequently leading to cell cycle arrest, apoptosis, and tumor growth inhibition (PMID: 29967249). |
DrugClasses | |
CAS Registry Number | 2089314-57-6 |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
AOH1160 | AOH1160 | 0 | 0 |
AOH1160 + Cisplatin | AOH1160 Cisplatin | 0 | 0 |